Shape: Cube

Modular Wood Environmental Deal Tombstone

Modular wood deal tombstone commemorating the acquisition of EWGroup, a Swedish environmental firm specializing in the remediation of contaminated materials. (23LJW111)

1 Image

Jnana-Roche Collaboration Commemorative

Lucite commemorative marking a collaboration between Jnana Therapeutics and Roche. The partnership centers on the development of small molecule drugs for the treatment of neurological diseases. (21AKL332)

2 Images
Side view of custom Lucite cube marking a partnership focused on the development of neurological treatments.

Crystal Biotech Offering Deal Tombstone

Crystal deal tombstone, featuring a cube on a cut-corner, commemorating a follow-on offering by Turning Point Therapeutics. (21alj013)

1 Image

Lucite with Embedded Booklet

Side view of Lucite with embedded booklet. (20AKL047)

1 Image

Ice Cube-Themed Lucite Tombstone

Custom Lucite tombstone marking the launch of a solar farm in University Park, Illinois. (9AKL684)

2 Images
Custom Lucite commemorating the launch of an Illinois-based solar farm.

Custom Lucite Core Values Award

2025 annual core values award designed for the credit and shopping platform Perpay. (25AKL156)

2 Images
Side view of core values award.

Sports Marketing Crystal Deal Toy

Slant crystal cube design marking the acquisition of Paragon Marketing Group. The sports marketing agency was originally founded as Halo Sports. (25AKL120)

1 Image

Crate-Themed Sustainable Packaging Deal Tombstone

Wood deal tombstone marking the sale of Singapore-based sustainable packaging company Greenpac. (23LJW030)

2 Images
Side view of wood crate-themed deal tombstone recognizing the sale of a sustainable packaging company.

Cancer Therapy First-in-Human Lucite Commemorative

Custom Lucite, incorporating an embedded vial, celebrating the first-in-human dosing in a Phase 1 clinical trial of cancer treatment developed by biotech company Immunome. (25ALJ040)

2 Images
Back view of a custom Lucite with an embedded vial marking the first patient dosed with a cancer therapy.